Cargando…

Active surveillance: a review of risk-based, dynamic monitoring

Active surveillance (AS) is an important treatment modality aiming to reduce the overtreatment of patients with prostate cancer (PCa) who have a low risk of disease reclassification. After enrolling in AS patients are actively monitored using different diagnostic tests (e.g., prostate specific-antig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nieboer, Daan, Tomer, Anirudh, Rizopoulos, Dimitris, Roobol, Monique J., Steyerberg, Ewout W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861286/ https://www.ncbi.nlm.nih.gov/pubmed/29594025 http://dx.doi.org/10.21037/tau.2017.12.27

Ejemplares similares

Personalized schedules for surveillance of low‐risk prostate cancer patients
por: Tomer, Anirudh, et al.
Publicado: (2018)

Personalised biopsy schedules based on risk of Gleason upgrading for patients with low‐risk prostate cancer on active surveillance
por: Tomer, Anirudh, et al.
Publicado: (2020)

Shared decision making of burdensome surveillance tests using personalized schedules and their burden and benefit
por: Tomer, Anirudh, et al.
Publicado: (2022)

Personalized Decision Making for Biopsies in Prostate Cancer Active Surveillance Programs
por: Tomer, Anirudh, et al.
Publicado: (2019)

A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy
por: Verbeek, Jan F.M., et al.
Publicado: (2019)

Rule-based versus probabilistic selection for active surveillance using three definitions of insignificant prostate cancer
por: Venderbos, Lionne D. F., et al.
Publicado: (2015)

A personalized and dynamic risk estimation model: The new paradigm in Barrett’s esophagus surveillance
por: Roumans, Carlijn A. M., et al.
Publicado: (2022)

Improving prediction models with new markers: a comparison of updating strategies
por: Nieboer, D., et al.
Publicado: (2016)

Comparison of biopsy under‐sampling and annual progression using hidden markov models to learn from prostate cancer active surveillance studies
por: Li, Weiyu, et al.
Publicado: (2020)

Assessing Discriminative Performance at External Validation of Clinical Prediction Models
por: Nieboer, Daan, et al.
Publicado: (2016)

The Patient Journey from Randomization to Detection of Prostate Cancer and Death: Results from ERSPC Rotterdam
por: Remmers, Sebastiaan, et al.
Publicado: (2023)

Validation of prediction models: examining temporal and geographic stability of baseline risk and estimated covariate effects
por: Austin, Peter C., et al.
Publicado: (2017)

Assessment of heterogeneity in an individual participant data meta‐analysis of prediction models: An overview and illustration
por: Steyerberg, Ewout W., et al.
Publicado: (2019)

Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome
por: Pereira-Azevedo, Nuno, et al.
Publicado: (2018)

Prostate cancer screening and active surveillance in the Western world
por: Roobol, Monique J.
Publicado: (2018)

Performance of IMPACT, CRASH and Nijmegen models in predicting six month outcome of patients with severe or moderate TBI: an external validation study
por: Majdan, Marek, et al.
Publicado: (2014)

Active surveillance for prostate cancer—will the discoveries of the last 5 years change the future?
por: Roobol, Monique J.
Publicado: (2021)

Using the Movember Foundation’s GAP3 cohort to measure the effect of active surveillance on patient-reported urinary and sexual function—a retrospective study in low-risk prostate cancer patients
por: Crump, R. Trafford, et al.
Publicado: (2021)

Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database
por: Beckmann, Kerri R., et al.
Publicado: (2022)

Identifying trauma patients with benefit from direct transportation to Level-1 trauma centers
por: Sewalt, Charlie A., et al.
Publicado: (2021)

Updating the Rotterdam Prostate Cancer Risk Calculator with Invasive Cribriform and/or Intraductal Carcinoma for Men with a Prior Negative Biopsy
por: Remmers, Sebastiaan, et al.
Publicado: (2021)

Predicting biochemical recurrence and prostate cancer‐specific mortality after radical prostatectomy: comparison of six prediction models in a cohort of patients with screening‐ and clinically detected prostate cancer
por: Remmers, Sebastiaan, et al.
Publicado: (2019)

Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium
por: Olivier, Jonathan, et al.
Publicado: (2022)

Monitoring prognosis in severe traumatic brain injury
por: Maas, Andrew IR, et al.
Publicado: (2014)

Active surveillance for prostate cancer
por: Shill, Daniela K., et al.
Publicado: (2021)

Active Surveillance for Prostate Cancer: Past, Current, and Future Trends
por: de Vos, Ivo I., et al.
Publicado: (2023)

Predicting Low-Risk Prostate Cancer from Transperineal Saturation Biopsies
por: van Leeuwen, Pim J., et al.
Publicado: (2016)

A literature review to understand health literacy in men with prostate cancer on active surveillance
por: Beyer, Katharina, et al.
Publicado: (2023)

Personalized screening intervals for kidney function in patients with chronic heart failure: a modeling study
por: Schuurman, Anne-Sophie, et al.
Publicado: (2021)

Handling of Missing Outcome Data in Traumatic Brain Injury Research: A Systematic Review
por: Richter, Sophie, et al.
Publicado: (2019)

Active surveillance for low-risk prostate cancer – in pursuit of a standardized protocol
por: Sosnowski, Roman, et al.
Publicado: (2020)

Active surveillance for low-risk prostate cancer: well established, yet avoided?
por: Sosnowski, Roman, et al.
Publicado: (2022)

A first step towards a global nomogram to predict disease progression for men on active surveillance
por: Van Hemelrijck, Mieke, et al.
Publicado: (2021)

Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative
por: Remmers, Sebastiaan, et al.
Publicado: (2022)

Kidney function and the risk of sudden cardiac death in the general population
por: van der Burgh, Anna C, et al.
Publicado: (2022)

Predictive accuracy of risk factors and markers: a simulation study of the effect of novel markers on different performance measures for logistic regression models
por: Austin, Peter C, et al.
Publicado: (2013)

Clinical prediction models: a practical approach to development, validation, and updating
por: Steyerberg, Ewout W
Publicado: (2019)

Clinical prediction models: a practical approach to development, validation, and updating
por: Steyerberg, Ewout W
Publicado: (2009)

Clinical prediction models : a practical approach to development, validation, and updating /
por: Steyerberg, Ewout W.
Publicado: (2009)

Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study
por: Leening, Maarten J G, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fd0pn1u03aieq87pa0q81rbva3